Predictors of rapidly progressive glomerulonephritis in acute poststreptococcal glomerulonephritis
Göster/ Aç
Erişim
info:eu-repo/semantics/closedAccessTarih
2023Yazar
Karakaya, DenizGüngör, Tülin
Kargin Çakıcı, Evrim
Yazılıtaş, Fatma
Çelikkaya, Evra
Yücebaş, Sait Can
Bülbül, Mehmet
Üst veri
Tüm öğe kaydını gösterKünye
Karakaya, D., Güngör, T., Kargin Çakıcı, E., Yazılıtaş, F., Çelikkaya, E., Yücebaş, S. C., & Bülbül, M. (2023). Predictors of rapidly progressive glomerulonephritis in acute poststreptococcal glomerulonephritis. Pediatric Nephrology, 1–7. https://doi.org/10.1007/s00467-023-05935-9Özet
Background Acute post-streptococcal glomerulonephritis (APSGN) is an immune-mediated inflammatory respsonse in the kidneys caused by nephritogenic strains of group A (3-hemolytic streptococcus (GAS). The present study aimed to present a large patient cohort of APSGN patients to determine the factors that can be used for predicting the prognosis and progression to rapidly progressive glomerulonephritis (RPGN).Methods The study included 153 children with APSGN that were seen between January 2010 and January 2022. Inclusion criteria were age 1-18 years and follow-up of >= 1 years. Patients with a diagnosis that could not be clearly proven clinically or via biopsy and with prior clinical or histological evidence of underlying kidney disease or chronic kidney disease (CKD) were excluded from the study.Results Mean age was 7.36 +/- 2.92 years, and 30.7% of the group was female. Among the 153 patients, 19 (12.4%) progressed to RPGN. The complement factor 3 and albumin levels were significantly low in the patients who had RPGN (P = 0.019). Inflammatory parameters, such as C-reactive protein (CRP), platelet-to-lymphocyte ratio, CRP/albumin ratio, and the erythrocyte sedimentation rate level at presentation were significantly higher in the patients with RPGN (P < 0.05). Additionally, there was a significant correlation between nephrotic range proteinuria and the course of RPGN (P = 0.024).Conclusions We suggest the possibility that RPGN can be predicted in APSGN with clinical and laboratory findings.